12:00 AM
 | 
Oct 18, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Target Now: Pilot trial data

A pilot trial in 66 refractory metastatic cancer patients who received treatment as determined by Target Now showed that 18 (27%) had a...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >